Stocktoria

Lyell Immunopharma, Inc. LYEL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-17

Lyell Immunopharma, Inc. institutional holders

InvestorSharesValue% of company
MILLENNIUM MANAGEMENT LLC458,905$9.2M2.16%
CITADEL ADVISORS LLC393,462$7.9M1.85%
RENAISSANCE TECHNOLOGIES LLC116,411$2.3M0.55%
Point72 Asset Management, L.P.21,292$427,1180.1%
TWO SIGMA INVESTMENTS, LP11,585$232,3950.05%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.